Log in to save to my catalogue

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with d...

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with d...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_883014c8faa04270b24b06a635cda57f

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations

About this item

Full title

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations

Publisher

London: Nature Publishing Group UK

Journal title

Cell death & disease, 2024-01, Vol.15 (1), p.34-34, Article 34

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Intrahepatic cholangiocarcinoma (ICC) is the second most common malignancy among primary liver cancers, with an increasing overall incidence and poor prognosis. The intertumoral and intratumoral heterogeneity of ICC makes it difficult to find efficient drug therapies. Therefore, it is essential to identify tumor suppressor genes and oncogenes that...

Alternative Titles

Full title

The heterogeneity of signaling pathways and drug responses in intrahepatic cholangiocarcinoma with distinct genetic mutations

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_883014c8faa04270b24b06a635cda57f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_883014c8faa04270b24b06a635cda57f

Other Identifiers

ISSN

2041-4889

E-ISSN

2041-4889

DOI

10.1038/s41419-023-06406-7

How to access this item